NCT00358163 2022-04-29
Trial of PTK787/ZK 222584 Plus Paclitaxel
Dana-Farber Cancer Institute
Phase 1 Terminated
Clinical Trials
8 trialsNCT00615160 2021-10-06
PTK/ZK in Disseminated Malignant Melanoma
University Hospital Schleswig-Holstein
Phase 1/2 Terminated
NCT00216047 2015-12-09
PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 1/2 Terminated
NCT00511043 2014-12-09
PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
Duke University
Phase 2 Terminated
NCT00240162 2014-09-17
PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma
Washington University School of Medicine
Phase 2 Terminated
NCT00263198 2013-05-07
PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT00293371 2012-10-11
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
University of California, San Francisco
Phase 1/2 Terminated
NCT00281125 2012-03-19
Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
Nevada Cancer Institute
Phase 1/2 Terminated